Beijing Unisplendour Pharmaceutical Co., Ltd.

Company Description

Who Beijing Unisplendour Pharmaceutical Co., Ltd.?
Our company was founded in 1993 (hereinafter referred to as Unisplendour), formerly known as Beijing Tsinghua Unisplendour Pharmaceutical Factory.

Beijing Tsinghua Unisplendour Pharmaceutical Co., Ltd. (hereinafter referred to as Tsinghua Unisplendour) is a subsidiary of Tsinghua Holdings Co., Ltd. (hereinafter referred as THHC). This is approved by the State Council of the People's Republic of China. THHC is a solely state-owned limited liability corporation founded by Tsinghua University based on the integration of enterprises under Tsinghua University. THHC focuses on industrialization of technical achievements, incubation of high-tech enterprises, investment management, asset/capital operation, etc.

In 2010, Waranty Asset Management Co., Ltd. invested in Tsinghua Unisplendour and changed the name into Beijing Unisplendour Pharmaceutical Co., Ltd., to accelerate internationalization and industrialization of health and pharm.

Based on advanced science and technology of Tsinghua, through a series of restructuring, introduction of strategic investors, Unisplendour has gradually developed into a comprehensive large pharmaceutical company. Our company has chemical drugs, herbal medicines, biological products, pharmaceutical intermediates, APIs with large-scale production base, formed the full chain of pharmaceutical industry.

What We Do?
We are a professional manufacturer and distributor in overseas and domestic markets. We can provide OEM service and also provide dossiers for registration in target country.

As the manufacturer of pharmaceutical preparations with one of the largest construction areas of single-plant, Unisplendour has the production lines of injection, tablet, capsule, ointment, etc. Unisplendour is manufacturing products under strictly quality control and according to CGMP. The production capacity of annual output is 50 million of the Cephalosporins for injection, 15 million of creams, gels, and 200 million of tablets.

Vision and Prospect
We aim to promote the culture of "Care All the Human Life" in development, manufacturing and marketing of medicines for the people along with and around us in the entire processes.

With the Tsinghua advanced technology of 20 years, inspired by our commitment of "Caring All the Human Life", following with international standards, Unisplendour will provide quality product for all the human life in the world.